IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v21y2001i5p357-367.html
   My bibliography  Save this article

Cost-effectiveness of Harm Reduction in Preventing Hepatitis C among Injection Drug Users

Author

Listed:
  • Harold A. Pollack

    (Department of Health Management and Policy, University of Michigan School of Public Health, Ann Arbor, Michigan)

Abstract

Objectives. Hepatitis C (HCV) has emerged as a major epidemic among injection drug users (IDUs), with observed prevalence exceeding 70% in many American and European cities. This article explores the potential of syringe exchange programs (SEPs) to reduce HCV incidence and prevalence. Design. A random-mixing epidemiological model is used to examine the potential impact of harm reduction interventions. Methods. Steady-state analysis is used to scrutinize the impact of SEP on HCV incidence and prevalence and to examine the accuracy of short-term incidence analysis in predicting long-run program effects. Results. SEP is predicted to have little impact on HCV incidence and prevalence within realistic populations of IDUs. Conclusions. Short-term incidence analysis substantially overstates SEP effectiveness and cost-effectiveness in preventing HCV. More comprehensive harm reduction models, coupled with referral of active IDUs to treatment, must complement syringe exchange to successfully contain highly infectious blood-borne diseases.

Suggested Citation

  • Harold A. Pollack, 2001. "Cost-effectiveness of Harm Reduction in Preventing Hepatitis C among Injection Drug Users," Medical Decision Making, , vol. 21(5), pages 357-367, October.
    • Handle: RePEc:sae:medema:v:21:y:2001:i:5:p:357-367
    DOI: 10.1177/0272989X0102100502
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/0272989X0102100502
    Download Restriction: no
    File URL: https://libkey.io/10.1177/0272989X0102100502?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Hagan, H. & Des Jarlais, D.C. & Friedman, S.R. & Purchase, D. & Alter, M.J., 1995. "Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program," American Journal of Public Health, American Public Health Association, vol. 85(11), pages 1531-1537.
    2. Garfein, R.S. & Vlahov, D. & Galai, N. & Doherty, M.C. & Nelson, K.E., 1996. "Viral infections in short-term injection drug users: The prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses," American Journal of Public Health, American Public Health Association, vol. 86(5), pages 655-661.
    3. Kaplan, Edward H. & Pollack, Harold, 1998. "Allocating HIV Prevention Resources," Socio-Economic Planning Sciences, Elsevier, vol. 32(4), pages 257-263, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. J. P. Caulkins & G. Feichtinger & C. Gavrila & A. Greiner & J. L. Haunschmied & P. M. Kort & G. Tragler, 2006. "Dynamic Cost-Benefit Analysis of Drug Substitution Programs," Journal of Optimization Theory and Applications, Springer, vol. 128(2), pages 279-294, February.
    2. Packham, Analisa, 2022. "Syringe exchange programs and harm reduction: New evidence in the wake of the opioid epidemic," Journal of Public Economics, Elsevier, vol. 215(C).
    3. Ava John-Baptiste & Man Yeung & Victoria Leung & Gabrielle Velde & Murray Krahn, 2012. "Cost Effectiveness of Hepatitis C-Related Interventions Targeting Substance Users and Other High-Risk Groups," PharmacoEconomics, Springer, vol. 30(11), pages 1015-1034, November.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Harold A. Pollack, 2001. "Can We Protect Drug Users from Hepatitis C?," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 20(2), pages 358-364.
    2. Chen, Huey T., 2010. "The bottom-up approach to integrative validity: A new perspective for program evaluation," Evaluation and Program Planning, Elsevier, vol. 33(3), pages 205-214, August.
    3. Brandeau, Margaret L. & Zaric, Gregory S. & Richter, Anke, 2003. "Resource allocation for control of infectious diseases in multiple independent populations: beyond cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 22(4), pages 575-598, July.
    4. Turgay Ayer & Can Zhang & Anthony Bonifonte & Anne C. Spaulding & Jagpreet Chhatwal, 2019. "Prioritizing Hepatitis C Treatment in U.S. Prisons," Operations Research, INFORMS, vol. 67(3), pages 853-873, May.
    5. Shiell, Alan & Law, Matthew G, 2001. "The cost of hepatitis C and the cost-effectiveness of its prevention," Health Policy, Elsevier, vol. 58(2), pages 121-131, November.
    6. Wilson, Amy R. & Kahn, James G., 2003. "Preventing HIV in injection drug users: exploring the tradeoffs between interventions," Socio-Economic Planning Sciences, Elsevier, vol. 37(4), pages 269-288, December.
    7. Lelutiu-Weinberger, Corina & Pouget, Enrique R. & Des Jarlais, Don D.C. & Cooper, Hannah L. & Scheinmann, Roberta & Stern, Rebecca & Strauss, Shiela M. & Hagan, Holly, 2009. "A meta-analysis of the hepatitis C virus distribution in diverse racial/ethnic drug injector groups," Social Science & Medicine, Elsevier, vol. 68(3), pages 579-590, February.
    8. Aktas, Emel & Ulengin, Fusun & Onsel Sahin, Sule, 2007. "A decision support system to improve the efficiency of resource allocation in healthcare management," Socio-Economic Planning Sciences, Elsevier, vol. 41(2), pages 130-146, June.
    9. Sakshi Mohan & Simon Walker & Freddie Sengooba & Elizabeth Ekirapa Kiracho & Chrispus Mayora & Aloysius Ssennyonjo & Candia Tom Aliti & Paul Revill, 2023. "Supporting the revision of the health benefits package in Uganda: A constrained optimisation approach," Health Economics, John Wiley & Sons, Ltd., vol. 32(6), pages 1244-1255, June.
    10. Arielle Lasry & Stephanie Sansom & Katherine Hicks & Vladislav Uzunangelov, 2011. "A model for allocating CDC’s HIV prevention resources in the United States," Health Care Management Science, Springer, vol. 14(1), pages 115-124, March.
    11. Zoë K. Harris, 2006. "Efficient allocation of resources to prevent HIV infection among injection drug users: the Prevention Point Philadelphia (PPP) needle exchange program," Health Economics, John Wiley & Sons, Ltd., vol. 15(2), pages 147-158, February.
    12. De Angelis, Vanda & Felici, Giovanni & Impelluso, Paolo, 2003. "Integrating simulation and optimisation in health care centre management," European Journal of Operational Research, Elsevier, vol. 150(1), pages 101-114, October.
    13. Lasry, Arielle & Zaric, Gregory S. & Carter, Michael W., 2007. "Multi-level resource allocation for HIV prevention: A model for developing countries," European Journal of Operational Research, Elsevier, vol. 180(2), pages 786-799, July.
    14. Suparna Das & Jenevieve Opoku & Adam Allston & Michael Kharfen, 2018. "Detecting spatial clusters of HIV and hepatitis coinfections," PLOS ONE, Public Library of Science, vol. 13(9), pages 1-13, September.
    15. Stephanie R. Earnshaw & Anke Richter & Stephen W. Sorensen & Thomas J. Hoerger & Katherine A. Hicks & Michael Engelgau & Ted Thompson & K. M. Venkat Narayan & David F. Williamson & Edward Gregg & Ping, 2002. "Optimal Allocation of Resources across Four Interventions for Type 2 Diabetes," Medical Decision Making, , vol. 22(1_suppl), pages 80-91, September.
    16. Golany, Boaz & Kaplan, Edward H. & Marmur, Abraham & Rothblum, Uriel G., 2009. "Nature plays with dice - terrorists do not: Allocating resources to counter strategic versus probabilistic risks," European Journal of Operational Research, Elsevier, vol. 192(1), pages 198-208, January.
    17. Montoya, Isaac D. & Atkinson, John S. & Lichtiger, Benjamin & Whitsett, Donna D., 2003. "Prevalence of hepatitis C in a drug using and non-using welfare population," Health Policy, Elsevier, vol. 64(2), pages 221-228, May.
    18. Richter, Anke & Hicks, Katherine A. & Earnshaw, Stephanie R. & Honeycutt, Amanda A., 2008. "Allocating HIV prevention resources: A tool for state and local decision making," Health Policy, Elsevier, vol. 87(3), pages 342-349, September.
    19. Alexander Gutfraind & Basmattee Boodram & Nikhil Prachand & Atesmachew Hailegiorgis & Harel Dahari & Marian E Major, 2015. "Agent-Based Model Forecasts Aging of the Population of People Who Inject Drugs in Metropolitan Chicago and Changing Prevalence of Hepatitis C Infections," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-23, September.
    20. Margaret Brandeau & Gregory Zaric, 2009. "Optimal investment in HIV prevention programs: more is not always better," Health Care Management Science, Springer, vol. 12(1), pages 27-37, March.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:21:y:2001:i:5:p:357-367. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.